Researchers have been excited about the medication , a novel dual compound showing significant results in initial trials for size loss . It functions by modulating several pathways : GLP-1 and GIP, these, when activated , support influence cravings and boost energy expenditure . Preliminary findings demonstrate noteworthy size loss and possible … Read More